Hims & Hers Health has announced plans to acquire ZAVA, a leading European digital health platform, to accelerate its expansion into the UK, Germany, France, and Ireland markets.
The all-cash acquisition will leverage ZAVA’s established European operations to launch Hims & Hers’ personalized digital healthcare services across multiple European markets. ZAVA serves more than 1.3 million active customers and delivered nearly 2.3 million consultations in 2024 across its four European markets.
“The demand for simpler, more personalized healthcare is universal,” said Andrew Dudum, founder and CEO of Hims & Hers. “By leveraging ZAVA’s established European presence, cutting-edge technology, and deep customer understanding, we’re poised to fundamentally transform access to care for millions across Europe.”
The acquisition will allow Hims & Hers to establish its own branded presence in European markets while utilizing ZAVA’s robust platform and medical infrastructure. The company plans to offer personalized care across dermatology, weight loss, sexual health, and mental health, with access to British, German, and French healthcare providers in local languages.
“Wherever you live, the need is the same: healthcare that’s personal, trustworthy and fast,” said David Meinertz, co-founder and CEO of ZAVA. “By joining forces with Hims & Hers, we can put that standard within reach of millions more people across Europe. Together we’ll pair ZAVA’s trusted clinical services, established footprint, and deep understanding of the European healthcare landscape with the Hims & Hers experience.”
ZAVA operates as a comprehensive digital health platform offering weight management, women’s and men’s health, sexual health, general medicine, and skin and hair care services. The platform has been rated “outstanding” for leadership by the UK Care Quality Commission and maintains an in-house medical team providing 24/7 healthcare access.
The acquisition consideration will be funded entirely from Hims & Hers’ balance sheet and is expected to close in the second half of 2025. The company anticipates the deal will be accretive by 2026 and expects to continue global expansion as demand for personalized healthcare grows.
This strategic move represents a significant expansion for Hims & Hers beyond its established U.S. market, positioning the company to compete in the growing European digital health sector while maintaining its focus on personalized, accessible healthcare delivery.
